These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11910264)

  • 1. Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.
    Gijsman HJ; van Gerven JM; de Kam ML; Schoemaker RC; Pieters MS; Weemaes M; de Rijk R; van der Post J; Cohen AF
    J Clin Psychopharmacol; 2002 Apr; 22(2):183-9. PubMed ID: 11910264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
    J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron.
    Jacobs GE; Kamerling IM; de Kam ML; Derijk RH; van Pelt J; Zitman FG; van Gerven JM
    J Psychopharmacol; 2010 Jan; 24(1):65-72. PubMed ID: 18719048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of l-5-hydroxytryptophan in healthy subjects.
    Westenberg HG; Gerritsen TW; Meijer BA; van Praag HM
    Psychiatry Res; 1982 Dec; 7(3):373-85. PubMed ID: 6187038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children.
    Ryan ND; Birmaher B; Perel JM; Dahl RE; Meyer V; al-Shabbout M; Iyengar S; Puig-Antich J
    Arch Gen Psychiatry; 1992 Nov; 49(11):843-51. PubMed ID: 1444721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.
    Meltzer HY; Maes M
    Psychopharmacology (Berl); 1994 May; 114(4):635-43. PubMed ID: 7855226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated doses of L-5-hydroxytryptophan and carbidopa on prolactin and aldosterone secretion in man.
    Vlasses PH; Rotmensch HH; Swanson BN; Clementi RA; Ferguson RK
    J Endocrinol Invest; 1989 Feb; 12(2):87-91. PubMed ID: 2474017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK/PD modeling of 5-hydroxytryptophan (5-HTP) challenge test with cortisol measurement in serum and saliva.
    Guan Z; Jacobs G; van Pelt H; Van Gerven JMA; Burggraaf J; Zhao W
    Pharmacol Res Perspect; 2020 Apr; 8(2):e00574. PubMed ID: 32168433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.
    van Vliet IM; Slaap BR; Westenberg HG; Den Boer JA
    Eur Neuropsychopharmacol; 1996 May; 6(2):103-10. PubMed ID: 8791035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral conversion of L-5-hydroxytryptophan to serotonin induces drinking in rats.
    Kikta DC; Threatte RM; Barney CC; Fregly MJ; Greenleaf JE
    Pharmacol Biochem Behav; 1981 Jun; 14(6):889-93. PubMed ID: 6973156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central serotonergic hypofunction in autism: results of the 5-hydroxy-tryptophan challenge test.
    Croonenberghs J; Wauters A; Deboutte D; Verkerk R; Scharpe S; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):449-55. PubMed ID: 17693983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic glutamate levels following serotonergic stimulation: a pilot study using 7-Tesla magnetic resonance spectroscopy in healthy volunteers.
    Jacobs GE; der Grond Jv; Teeuwisse WM; Langeveld TJ; van Pelt J; Verhagen JC; de Kam ML; Cohen AF; Zitman FG; van Gerven JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):486-91. PubMed ID: 20138102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.
    Lee MA; Nash JF; Barnes M; Meltzer HY
    Psychopharmacology (Berl); 1991; 103(2):258-64. PubMed ID: 1851310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine responses to serotonergic agents in alcoholics.
    Lee MA; Meltzer HY
    Biol Psychiatry; 1991 Nov; 30(10):1017-30. PubMed ID: 1756196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged deficits in presynaptic serotonin function following withdrawal from chronic cocaine exposure as revealed by 5-HTP-induced head-twitch response in mice.
    Darmani NA; Shaddy J; Elder EL
    J Neural Transm (Vienna); 1997; 104(11-12):1229-47. PubMed ID: 9503268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instability in the response to DST in major depressions during treatment with 5-hydroxytryptophan and carbidopa.
    Lopez-Ibor JJ; Saiz-Ruiz J; Perez de los Cobos JC
    Acta Psychiatr Belg; 1985; 85(3):450-8. PubMed ID: 3876688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat.
    Limón-Bernal E; Roa-Coria JE; Zúñiga-Romero Á; Huerta-Cruz JC; Ruíz-Velasco IRC; Flores-Murrieta FJ; Lara-Padilla E; Reyes-García JG; Rocha-González HI
    Behav Pharmacol; 2021 Aug; 32(5):368-381. PubMed ID: 33660661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.